Browse studies, page 671

Page 671 of 1,298, newest first. Search them all at once, ranked by relevance, in Evidence Hub.

• Once-daily, 3-day azithromycin versus a three-times-daily, 10-day course of co-amoxiclav in the treatment of adults with lower respiratory tract infections: results of a randomized, double-blind comparative study The Journal of antimicrobial chemotherapy, 1996
• Etiology, susceptibility, and treatment of acute bacterial exacerbations of complicated chronic bronchitis in the primary care setting: ciprofloxacin 750 mg b.i.d. versus clarithromycin 500 mg b.i.d. Bronchitis Study Group Clinical therapeutics, 1998
• Randomized, double-blind study of ciprofloxacin and cefuroxime axetil for treatment of acute bacterial exacerbations of chronic bronchitis. The Bronchitis Study Group Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 1998
• Phase III, randomized, double-blind study of clarithromycin extended-release and immediate-release formulations in the treatment of patients with acute exacerbation of chronic bronchitis Clinical therapeutics, 2000
• Controlled multicentric study comparing cefixime and amoxicillin in the treatment of lower respiratory tract infections in adults Presse medicale (Paris, France : 1983), 1989
• Comparative study of clarithromycin and ampicillin in the treatment of patients with acute bacterial exacerbations of chronic bronchitis The Journal of antimicrobial chemotherapy, 1991
• Primary prevention of acute respiratory tract infections in children using a bacterial immunostimulant: a double-masked, placebo-controlled clinical trial Clinical therapeutics, 2000
• Efficacy and safety of azithromycin vs levofloxacin in the outpatient treatment of acute bacterial exacerbations of chronic bronchitis Chest, 2003
• A comparison of 5 days of dirithromycin and 7 days of clarithromycin in acute bacterial exacerbation of chronic bronchitis The Journal of antimicrobial chemotherapy, 1995
• Assessment of the bioequivalence of two formulations of clarithromycin extended-release 500-mg tablets under fasting and fed conditions: a single-dose, randomized, open-label, two-period, two-way crossover study in healthy Jordanian male volunteers Clinical therapeutics, 2008
• A short (3-day) course of azithromycin tablets versus a 10-day course of amoxycillin-clavulanic acid (co-amoxiclav) in the treatment of adults with lower respiratory tract infections and effects on long-term outcome International journal of antimicrobial agents, 1997
• Effect of procalcitonin-based guidelines vs standard guidelines on antibiotic use in lower respiratory tract infections: the ProHOSP randomized controlled trial JAMA, 2009
• Efficacy and safety of a 10-day course of 400 or 600 milligrams of grepafloxacin once daily for treatment of acute bacterial exacerbations of chronic bronchitis: comparison with a 10-day course of 500 milligrams of ciprofloxacin twice daily Antimicrobial agents and chemotherapy, 1998
• The safety and efficacy of short course (5-day) moxifloxacin vs. azithromycin in the treatment of patients with acute exacerbation of chronic bronchitis Respiratory medicine, 2000
• Five days of cefprozil versus 10 days of clarithromycin in the treatment of an acute exacerbation of chronic bronchitis Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology, 2001
• Once-daily azithromycin for 3 days compared with clarithromycin for 10 days for acute exacerbation of chronic bronchitis: a multicenter, double-blind, randomized study Treatments in respiratory medicine, 2005
• Open-label, randomized comparison of the efficacy and tolerability of clarithromycin, levofloxacin, and cefuroxime axetil in the treatment of adults with acute bacterial exacerbations of chronic bronchitis Clinical therapeutics, 2002
• Procalcitonin guided antibiotic therapy and hospitalization in patients with lower respiratory tract infections: a prospective, multicenter, randomized controlled trial BMC health services research, 2007
• A comparison of cefditoren pivoxil and amoxicillin/ clavulanate in the treatment of community-acquired pneumonia: a multicenter, prospective, randomized, investigator-blinded, parallel-group study Clinical therapeutics, 2002
• A comparison of 5-day courses of dirithromycin and azithromycin in the treatment of acute exacerbations of chronic obstructive pulmonary disease Clinical therapeutics, 2003
• Randomized, double-blind study of short-course (5 day) grepafloxacin versus 10 day clarithromycin in patients with acute bacterial exacerbations of chronic bronchitis The Journal of antimicrobial chemotherapy, 1999
• Comparison of once-daily cephalosporin regimens for community-acquired lower respiratory tract infections in patients with chronic lung disease Clinical therapeutics, 1989
• Trovafloxacin versus amoxicillin/clavulanic acid in the treatment of acute exacerbations of chronic obstructive bronchitis European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology, 1998
• Efficacy and safety of 3-day azithromycin versus 5-day moxifloxacin for the treatment of acute bacterial exacerbations of chronic bronchitis International journal of antimicrobial agents, 2007
• Randomized, double-blind study of grepafloxacin versus amoxycillin in patients with acute bacterial exacerbations of chronic bronchitis The Journal of antimicrobial chemotherapy, 1997
• Sparfloxacin vs ofloxacin in the treatment of acute bacterial exacerbations of chronic bronchitis: a multicenter, double-blind, randomized, comparative study. Sparfloxacin Multicenter ABECB Study Group Chest, 1998
• Esberitox N as supportive therapy when providing standard antibiotic treatment in subjects with a severe bacterial infection (acute exacerbation of chronic bronchitis). A multicentric, prospective, double-blind, placebo-controlled study Chemotherapy, 2002
• A double-blind study of once-daily temafloxacin in the treatment of bacterial lower respiratory tract infections The Journal of antimicrobial chemotherapy, 1991
• Effect of ELOM-080 on exacerbations and symptoms in COPD patients with a chronic bronchitis phenotype - a post-hoc analysis of a randomized, double-blind, placebo-controlled clinical trial International journal of chronic obstructive pulmonary disease, 2016
• Loracarbef (LY163892) versus amoxicillin/clavulanate in the treatment of acute bacterial exacerbations of chronic bronchitis Clinical therapeutics, 1992
• Azithromycin versus pivampicillin in the treatment of acute exacerbations of chronic bronchitis: a single-blind, double-dummy, multicentre study The Journal of international medical research, 2000
• A comparison of gemifloxacin and clarithromycin in acute exacerbations of chronic bronchitis and long-term clinical outcomes Clinical therapeutics, 2002
• Pharmacokinetics and pharmacodynamics of oral grepafloxacin in patients with acute bacterial exacerbations of chronic bronchitis The Journal of antimicrobial chemotherapy, 1997
• Short-course therapy of acute bacterial exacerbation of chronic bronchitis: a double-blind, randomized, multicenter comparison of extended-release versus immediate-release clarithromycin Current medical research and opinion, 2003
• A multicentre study comparing the safety and efficacy of dirithromycin with erythromycin in the treatment of bronchitis The Journal of antimicrobial chemotherapy, 1993
• Comparison of azithromycin and co-amoxiclav in the treatment of acute tracheobronchitis and acute infectious exacerbations of chronic bronchitis in adults. Azithromycin Study Group The Journal of international medical research, 1996
• Doxycycline and minocycline in the treatment of respiratory infections: a double-blind comparative clinical, microbiological and pharmacokinetic study The Journal of antimicrobial chemotherapy, 1989
• Efficacy and tolerability of brodimoprim in respiratory tract infections Journal of chemotherapy (Florence, Italy), 1993
• Subcutaneous administration of hyaluronan reduces the number of infectious exacerbations in patients with chronic bronchitis American journal of respiratory and critical care medicine, 1996
• Five-day moxifloxacin therapy compared with 7-day co-amoxiclav therapy for the treatment of acute exacerbation of chronic bronchitis International journal of antimicrobial agents, 2004
• Short-term and long-term outcomes of moxifloxacin compared to standard antibiotic treatment in acute exacerbations of chronic bronchitis Chest, 2004
• Antibiotic treatment and factors influencing short and long term outcomes of acute exacerbations of chronic bronchitis Thorax, 2006
• Short-course moxifloxacin therapy for treatment of acute bacterial exacerbations of chronic bronchitis. The Bronchitis Study Group Respiratory medicine, 2000
• A phase II study of antofloxacin hydrochloride, a novel fluoroquinolone, for the treatment of acute bacterial infections Chemotherapy, 2010
• Efficacy and safety of clarithromycin compared to cefixime as outpatient treatment of lower respiratory tract infections Chest, 1993
• Dirithromycin versus amoxiclav in the treatment of acute exacerbations of chronic bronchitis The Journal of international medical research, 1997
• Treatment of acute exacerbations of chronic bronchitis. Multicenter, randomized comparative study of cefuroxime axetil versus ofloxacin Fortschritte der Medizin, 1991
• Cefaclor af versus amoxycillin/clavulanate in acute bacterial exacerbations of chronic bronchitis: a randomised multicentre study International journal of clinical practice, 1999
• Clinical evaluation of combination therapy of sulbactam/cefoperazone and aminoglycoside in respiratory tract infections The Japanese journal of antibiotics, 1994
• The pattern of micro-organisms and the efficacy of new macrolide in acute lower respiratory tract infections Respirology (Carlton, Vic.), 1998
• Controlled prospective study of oral amoxycillin/clavulanate vs ciprofloxacin in acute exacerbations of chronic bronchitis The Journal of antimicrobial chemotherapy, 1989
• A controlled trial of a killed Haemophilus influenzae vaccine for prevention of acute exacerbations of chronic bronchitis Australian and New Zealand journal of medicine, 1991
• Efficacy and tolerability of azithromycin versus amoxicillin/clavulanic acid in acute purulent exacerbation of chronic bronchitis Journal of chemotherapy (Florence, Italy), 1995
• A comparison of pivmecillinam/pivampicillin and amoxycillin in acute exacerbations of chronic bronchitis The Journal of international medical research, 1987
• Cefaclor AF vs Clarithromycin in acute exacerbation of chronic bronchitis (B3M-PK-AJBG) JPMA. The Journal of the Pakistan Medical Association, 2003
• Dirithromycin concentrations in bronchial mucosa and secretions Respiration; international review of thoracic diseases, 1998
• Randomised double-blind comparison of oral gatifloxacin and co-amoxiclav for acute exacerbation of chronic Bronchitis European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology, 2003
• Predictors of chronic obstructive pulmonary disease exacerbation reduction in response to daily azithromycin therapy American journal of respiratory and critical care medicine, 2014
• Randomized comparative study of cefixime versus cephalexin in acute bacterial exacerbations of chronic bronchitis Antimicrobial agents and chemotherapy, 1990
• Time course of recovery of health status following an infective exacerbation of chronic bronchitis Thorax, 2003
• Treating acute bacterial exacerbations of chronic bronchitis in patients unresponsive to previous therapy: sparfloxacin versus clarithromycin Clinical therapeutics, 1999
• Comparative activities of pefloxacin and ciprofloxacin in the treatment of chronic respiratory tract infections Journal of chemotherapy (Florence, Italy), 1995
• Telithromycin is as effective as amoxicillin/clavulanate in acute exacerbations of chronic bronchitis Respiratory medicine, 2002
• Efficacy of gemifloxacin in acute exacerbations of chronic bronchitis: a randomised, double-blind comparison with trovafloxacin Journal of chemotherapy (Florence, Italy), 2001
• Comparison of spiramycin and clarithromycin for community-acquired lower respiratory tract infections International journal of clinical practice, 1999
• Clinical experience with 1000 patients treated with cefetamet pivoxil Current medical research and opinion, 1989
• Efficacy and safety of ciprofloxacin in patients with respiratory infections in comparison with amoxycillin The Journal of antimicrobial chemotherapy, 1986
• Effect of procalcitonin-guided treatment on antibiotic use and outcome in lower respiratory tract infections: cluster-randomised, single-blinded intervention trial Lancet (London, England), 2004
• Treatment of exacerbations of chronic obstructive pulmonary disease with pristinamycin Revue des maladies respiratoires, 2004
• Moxifloxacin versus amoxicillin/clavulanic acid in outpatient acute exacerbations of COPD: MAESTRAL results The European respiratory journal, 2012
• The clinical efficacy and safety of bacampicillin twice daily in comparative studies The Journal of international medical research, 1987
• Effects of food on the pharmacokinetics of sparfloxacin Clinical therapeutics, 1999
• Betalactam therapy and intestinal flora Journal of chemotherapy (Florence, Italy), 1995
• Clinical efficacy of azithromycin in lower respiratory tract infections Journal of chemotherapy (Florence, Italy), 1993
• Pharmacokinetics and tolerability of extended-release clarithromycin Clinical therapeutics, 2001
• Appropriate Use of Short-Course Antibiotics in Common Infections: Best Practice Advice From the American College of Physicians Annals of Internal Medicine, 2021
• Procalcitonin-guided antibiotic therapy algorithms for different types of acute respiratory infections based on previous trials Expert review of anti-infective therapy, 2018
• Moxifloxacin: a respiratory fluoroquinolone Expert opinion on pharmacotherapy, 2008
• Azithromycin for acute lower respiratory tract infections The Cochrane database of systematic reviews, 2015
• Sputum Color as a Marker for Bacteria in Acute Exacerbations of Chronic Obstructive Pulmonary Disease: A Systematic Review and Meta-analysis Annals of the American Thoracic Society, 2023
• Procalcitonin-guided algorithms of antibiotic therapy in community-acquired lower respiratory tract infections: a systematic review and meta-analysis of randomized controlled trials Zhonghua jie he he hu xi za zhi = Zhonghua jiehe he huxi zazhi = Chinese journal of tuberculosis and respiratory diseases, 2012
• Preventive treatment of chronic bronchitis: a meta-analysis of clinical trials with a bacterial extract (OM-85 BV) and a cost-effectiveness analysis Monaldi archives for chest disease = Archivio Monaldi per le malattie del torace, 1994
• Gemifloxacin for the treatment of community-acquired pneumonia and acute exacerbation of chronic bronchitis: a meta-analysis of randomized controlled trials Chinese medical journal, 2012
• Haemophilus influenzae oral vaccination for preventing acute exacerbations of chronic bronchitis and chronic obstructive pulmonary disease The Cochrane database of systematic reviews, 2014
• Penicillins vs trimethoprim-based regimens for acute bacterial exacerbations of chronic bronchitis: meta-analysis of randomized controlled trials Canadian family physician Medecin de famille canadien, 2009
• Meta-analysis of randomized controlled trials on the comparative efficacy and safety of azithromycin against other antibiotics for lower respiratory tract infections The Journal of antimicrobial chemotherapy, 2001
• Five-day dirithromycin therapy is as effective as seven-day erythromycin therapy for acute exacerbations of chronic bronchitis The Journal of antimicrobial chemotherapy, 1999
• Haemophilus influenzae oral vaccination for preventing acute exacerbations of chronic bronchitis and chronic obstructive pulmonary disease The Cochrane database of systematic reviews, 2017
• Literature survey on clinical efficacy and tolerability on cefetamet pivoxil: an analysis of 3,128 cases Respiration; international review of thoracic diseases, 1993
• Polyvalent mechanical bacterial lysate for the prevention of recurrent respiratory infections: a meta-analysis Pulmonary pharmacology & therapeutics, 2012
• Short- versus long-duration antimicrobial treatment for exacerbations of chronic bronchitis: a meta-analysis The Journal of antimicrobial chemotherapy, 2008
• Infection in the elderly: studies with lomefloxacin The American journal of medicine, 1992
• A Meta-analysis of Sequential Intravenous/Oral Moxifloxacin Monotherapy for Treatment of Skin and Skin Structure Infections Drug research, 2015
• Macrolides, quinolones and amoxicillin/clavulanate for chronic bronchitis: a meta-analysis The European respiratory journal, 2007
• The U.S. clinical experience with lomefloxacin, a new once-daily fluoroquinolone The American journal of medicine, 1992
• Azithromycin for acute lower respiratory tract infections The Cochrane database of systematic reviews, 2008
• Prophylactic antibiotics for adults with chronic obstructive pulmonary disease: a network meta-analysis The Cochrane database of systematic reviews, 2021
• Azithromycin for acute lower respiratory tract infections The Cochrane database of systematic reviews, 2004
• Case Study of the Effects of Office-Based Generic Drug Sampling on Antibiotic Drug Costs and First-Line Antibiotic Prescribing Ratios Journal of Managed Care Pharmacy, 2009
• Optimising antimicorbial use in aged-care homes Figshare, 2020